Edge Wealth Management’s Dare Bioscience DARE Stock Holding History

Edge Wealth Management’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-167	Closed	-$4K	–	195
2021 Q4	$4K	Hold	167	–	–	﹤0.01%	347
2021 Q3	$3K	Hold	167	–	–	﹤0.01%	385
2021 Q2	$4K	Hold	167	–	–	﹤0.01%	351
2021 Q1	$3K	Sell	167 -83	-33%	-$2.02K	﹤0.01%	358
2020 Q4	$4K	Hold	250	–	–	﹤0.01%	303
2020 Q3	$3K	Hold	250	–	–	﹤0.01%	376
2020 Q2	$3K	Hold	250	–	–	﹤0.01%	587
2020 Q1	$3K	Hold	250	–	–	﹤0.01%	516
2019 Q4	$2K	Hold	250	–	–	﹤0.01%	531
2019 Q3	$2K	Hold	250	–	–	﹤0.01%	523
2019 Q2	$3K	Buy	+250	New	+$2.97K	﹤0.01%	517

Other funds holding DARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SAM

Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Edge Wealth Management's DARE Position: Q1 2022 in Review

Edge Wealth Management sold out of Dare Bioscience (DARE) in Q1 2022, closing a stake of 167 shares — an estimated $4K sold.

Edge Wealth Management first reported a position in DARE in Q2 2019 and held it in 11 quarters. The position peaked at $4K in Q4 2021. 40 funds tracked by Wall St. Rank hold DARE as of Q1 2022.

Edge Wealth Management reported no remaining Dare Bioscience position as of Q1 2022 after selling out during the quarter.
Edge Wealth Management sold 167 Dare Bioscience shares in Q1 2022, an estimated $4K.
Edge Wealth Management first reported a position in Dare Bioscience in Q2 2019 and held it in 11 quarters.
Edge Wealth Management's Dare Bioscience position peaked at $4K in Q4 2021.
40 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2022.

Based on Edge Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.